Pharvaris Bv Stock Performance
| PHVS Stock | USD 21.90 0.46 2.06% |
On a scale of 0 to 100, Pharvaris holds a performance score of 8. The company holds a Beta of 1.51, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharvaris will likely underperform. Please check Pharvaris' potential upside, and the relationship between the jensen alpha and accumulation distribution , to make a quick decision on whether Pharvaris' historical price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.06) | Five Day Return (2.45) | Year To Date Return (15.35) | Ten Year Return (24.48) | All Time Return (24.48) |
1 | Pharvaris Presents Data at the Bradykinin Symposium 2024 | 09/05/2024 |
2 | Short Interest in Pharvaris Expands By .5 | 09/17/2024 |
3 | Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop | 10/03/2024 |
4 | Pharvaris Stock Price Down 7.9 percent Whats Next | 11/07/2024 |
5 | Pharvaris reports Q3 results | 11/14/2024 |
| Begin Period Cash Flow | 161.8 M |
Pharvaris |
Pharvaris Relative Risk vs. Return Landscape
If you would invest 1,755 in Pharvaris BV on September 1, 2024 and sell it today you would earn a total of 435.00 from holding Pharvaris BV or generate 24.79% return on investment over 90 days. Pharvaris BV is currently generating 0.4324% in daily expected returns and assumes 4.0536% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Pharvaris, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pharvaris Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharvaris' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharvaris BV, and traders can use it to determine the average amount a Pharvaris' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1067
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PHVS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Pharvaris is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharvaris by adding it to a well-diversified portfolio.
Pharvaris Fundamentals Growth
Pharvaris Stock prices reflect investors' perceptions of the future prospects and financial health of Pharvaris, and Pharvaris fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharvaris Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 892.61 M | ||||
| Shares Outstanding | 54.23 M | ||||
| Price To Book | 3.89 X | ||||
| EBITDA | (96.85 M) | ||||
| Net Income | (99.83 M) | ||||
| Cash And Equivalents | 201.38 M | ||||
| Cash Per Share | 5.96 X | ||||
| Total Debt | 238.91 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 12.85 X | ||||
| Book Value Per Share | 7.34 X | ||||
| Cash Flow From Operations | (93.05 M) | ||||
| Earnings Per Share | (2.73) X | ||||
| Market Capitalization | 1.21 B | ||||
| Total Asset | 398.69 M | ||||
| Retained Earnings | (265.92 M) | ||||
| Working Capital | 383.25 M | ||||
About Pharvaris Performance
Assessing Pharvaris' fundamental ratios provides investors with valuable insights into Pharvaris' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pharvaris is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 8.8 K | 6.7 K | |
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.25) | (0.27) | |
| Return On Equity | (0.26) | (0.28) |
Things to note about Pharvaris BV performance evaluation
Checking the ongoing alerts about Pharvaris for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharvaris BV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharvaris BV had very high historical volatility over the last 90 days | |
| Net Loss for the year was (99.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pharvaris BV currently holds about 201.38 M in cash with (93.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.96. | |
| Pharvaris BV has a frail financial position based on the latest SEC disclosures | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Pharvaris reports Q3 results |
- Analyzing Pharvaris' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharvaris' stock is overvalued or undervalued compared to its peers.
- Examining Pharvaris' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharvaris' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharvaris' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharvaris' stock. These opinions can provide insight into Pharvaris' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.